Treatment of older adults with acute myeloid leukemia: state of the art and current perspectives

被引：38
作者：
Sekeres, Miael A. [1 ]
机构：
[1] Cleveland Clin, Taussig Canc Inst, Dept Hematol Oncol & Blood Disorders, Cleveland, OH 44106 USA
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷 / 12期
关键词：
D O I：
10.3324/haematol.2008.000497
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1769 / 1772
页数：4
相关论文
共 31 条
[1]   Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age [J].
Alyea, EP ;
Kim, HT ;
Ho, V ;
Cutler, C ;
Gribben, J ;
DeAngelo, DJ ;
Lee, SJ ;
Windawi, S ;
Ritz, J ;
Stone, RM ;
Antin, JH ;
Soiffer, RJ .
BLOOD, 2005, 105 (04) :1810-1814
[2]  
[Anonymous], US INT PROJ AG SEX R
[3]   Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720 [J].
Baer, MR ;
George, SL ;
Dodge, RK ;
O'Loughlin, KL ;
Minderman, H ;
Caligiuri, MA ;
Anastasi, J ;
Powell, BL ;
Kolitz, JE ;
Schiffer, CA ;
Bloomfield, CD ;
Larson, RA .
BLOOD, 2002, 100 (04) :1224-1232
[4]  
Bloomfield CD, 1998, CANCER RES, V58, P4173
[5]   Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia:: results from Cancer and Leukemia Group B (CALGB 8461) [J].
Byrd, JC ;
Mrózek, K ;
Dodge, RK ;
Carroll, AJ ;
Edwards, CG ;
Arthur, DC ;
Pettenati, MJ ;
Patil, SR ;
Rao, KW ;
Watson, MS ;
Koduru, PRK ;
Moore, JO ;
Stone, RM ;
Mayer, RJ ;
Feldman, EJ ;
Davey, FR ;
Schiffer, CA ;
Larson, RA ;
Bloomfield, CD .
BLOOD, 2002, 100 (13) :4325-4336
[6]  
CAREY RW, 1975, CANCER-AM CANCER SOC, V36, P1560, DOI 10.1002/1097-0142(197511)36:5<1560::AID-CNCR2820360504>3.0.CO
[7]  
2-5
[8]   Treatment of newly-diagnosed acute myelogenous leukaemia in patients aged 80 years and above [J].
DeLima, M ;
Ghaddar, H ;
Pierce, S ;
Estey, E .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (01) :89-95
[9]  
DILLMAN RO, 1991, BLOOD, V78, P2520
[10]   Pre-treatment cytogenetics predict complete remission and long-term outcome in patients (Pts) ≥60 years with acute myeloid leukemia (AML):: Results from cancer and leukemia group B (CALGB) 8461. [J].
Farag, SS ;
Archer, KJ ;
Mrózek, K ;
Vardiman, JW ;
Carroll, AJ ;
Pettenati, MJ ;
Powell, BL ;
Moore, JO ;
Kolitz, JE ;
Baer, MR ;
Bigner, SH ;
Koduru, PR ;
Stamberg, J ;
Mayer, RJ ;
Stone, RM ;
Schiffer, CA ;
Larson, RA ;
Bloomfield, CD .
BLOOD, 2004, 104 (11) :164A-164A
1234